4.6 Article

The Reduction-insensitive Bonds of the MUC2 Mucin Are Isopeptide Bonds

Journal

JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 291, Issue 26, Pages 13580-13590

Publisher

AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
DOI: 10.1074/jbc.M116.726406

Keywords

intestine; mass spectrometry (MS); mucin; mucus; transglutaminase

Funding

  1. Swedish Research Council [746]
  2. Swedish Cancer Foundation
  3. Knut and Alice Wallenberg Foundation
  4. IngaBritt and Arne Lundberg Foundation
  5. Sahlgren's University Hospital (ALF)
  6. Wilhelm and Martina Lundgren's Foundation
  7. Torsten Soderbergs Stiftelse
  8. The Sahlgrenska Academy
  9. National Institutes of Health from NIAID [U01AI095473]
  10. Swedish Foundation for Strategic Research-The Mucus-Bacteria-Colitis Center of the Innate Immunity Program
  11. Swedish Cystic Fibrosis Foundation
  12. Erica Lederhausen's Foundation
  13. Lederhausen's Center for Cystic Fibrosis Research

Ask authors/readers for more resources

The main structural component of the mucus in the gastrointestinal tract is the MUC2 mucin. It forms large networks that in colon build the loose outer mucous layer that provides the habitat for the commensal flora and the inner mucous layer that protects the epithelial cells by being impenetrable to bacteria. The epithelial cells in mice lacking MUC2 are not adequately protected from bacteria, resulting in inflammation and the development of colon cancer as found in human ulcerative colitis. Correct processing of the MUC2 mucin is the basis for the building of these protective networks. During the biosynthesis of the MUC2 mucin, post-translational modifications are formed resulting in reduction-insensitive bonds between MUC2 monomers. By the use of -glutamyltranspeptidase and isopeptidase activity in leech saliva, we could show that the molecular nature of these reduction-insensitive bonds is isopeptide bonds formed between side chains of lysine and glutamine. Transglutaminase 2 has an affinity to the MUC2 CysD2 domain in the nanomolar range and can catalyze its cross-linking. By using mass spectrometry, we identified MUC2 residues involved in this cross-linking. This shows for the first time that transamidation is not only stabilizing the skin and the fibrin clot, but is also important for the correct intracellular processing of MUC2 to generate protective mucus.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available